Kevin Xu is the CEO of MEBO International, a California and Beijing based intellectual property Management Company responsible for managing “Human Body Regenerative Restoration Science” (HBRRS). CEO of Skingenix, California based Company exclusively working on drug development in the field of damaged organ regeneration. Founder of MEBO campus, a virtual educational platform for organ regeneration science. He is a member of the Young Entrepreneur Council (YEC), an appointee of the California-China Trade and Investment Advisory Group, and the founder of the National Rongxiang Xu foundation and Human Heritage Project. Kevin also receive the Empact 100 recognition at United Nation Headquarter. Kevin serves on the board of the Asian Advisory Board of the USC Davis School of gerontology and Board member of Dr. Rongxiang xu center of regenerative therapuetic at Beth iseral Deaconess Medical center in Harvard Medical school. He earned his BA in neuroscience at USC.